HRP20010332B1 - Farmaceutski pripravak moksifloksacina - Google Patents

Farmaceutski pripravak moksifloksacina

Info

Publication number
HRP20010332B1
HRP20010332B1 HR20010332A HRP20010332A HRP20010332B1 HR P20010332 B1 HRP20010332 B1 HR P20010332B1 HR 20010332 A HR20010332 A HR 20010332A HR P20010332 A HRP20010332 A HR P20010332A HR P20010332 B1 HRP20010332 B1 HR P20010332B1
Authority
HR
Croatia
Prior art keywords
moxifloxacin
pharmaceutical preparation
disintegrant
hydrate
lactose
Prior art date
Application number
HR20010332A
Other languages
English (en)
Croatian (hr)
Inventor
Bosche Patrick
Friedrich Mahler Hans
Weisemann Claus
Original Assignee
Bayer Schering Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7889824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20010332(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Aktiengesellschaft filed Critical Bayer Schering Pharma Aktiengesellschaft
Publication of HRP20010332A2 publication Critical patent/HRP20010332A2/hr
Publication of HRP20010332B1 publication Critical patent/HRP20010332B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HR20010332A 1998-11-10 1999-10-29 Farmaceutski pripravak moksifloksacina HRP20010332B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19855758 1998-11-10
PCT/EP1999/008230 WO2000027398A1 (de) 1998-11-10 1999-10-29 Pharmazeutische zubereitung von moxifloxacin

Publications (2)

Publication Number Publication Date
HRP20010332A2 HRP20010332A2 (en) 2002-06-30
HRP20010332B1 true HRP20010332B1 (hr) 2011-01-31

Family

ID=7889824

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010332A HRP20010332B1 (hr) 1998-11-10 1999-10-29 Farmaceutski pripravak moksifloksacina

Country Status (41)

Country Link
US (1) US6610327B1 (cg-RX-API-DMAC7.html)
EP (1) EP1128831B1 (cg-RX-API-DMAC7.html)
JP (1) JP4809978B2 (cg-RX-API-DMAC7.html)
KR (1) KR100650489B1 (cg-RX-API-DMAC7.html)
CN (1) CN1149993C (cg-RX-API-DMAC7.html)
AR (1) AR021074A1 (cg-RX-API-DMAC7.html)
AT (1) ATE279193T1 (cg-RX-API-DMAC7.html)
AU (1) AU745282B2 (cg-RX-API-DMAC7.html)
BG (1) BG64974B1 (cg-RX-API-DMAC7.html)
BR (2) BRPI9915208B8 (cg-RX-API-DMAC7.html)
CA (1) CA2349161C (cg-RX-API-DMAC7.html)
CO (1) CO5070571A1 (cg-RX-API-DMAC7.html)
CU (1) CU23260B7 (cg-RX-API-DMAC7.html)
CZ (1) CZ292069B6 (cg-RX-API-DMAC7.html)
DE (1) DE59910858D1 (cg-RX-API-DMAC7.html)
DK (1) DK1128831T3 (cg-RX-API-DMAC7.html)
EE (1) EE04418B1 (cg-RX-API-DMAC7.html)
ES (1) ES2229786T3 (cg-RX-API-DMAC7.html)
HK (1) HK1042245B (cg-RX-API-DMAC7.html)
HN (1) HN1999000183A (cg-RX-API-DMAC7.html)
HR (1) HRP20010332B1 (cg-RX-API-DMAC7.html)
HU (1) HU229065B1 (cg-RX-API-DMAC7.html)
ID (1) ID29089A (cg-RX-API-DMAC7.html)
IL (2) IL142642A0 (cg-RX-API-DMAC7.html)
MA (1) MA26757A1 (cg-RX-API-DMAC7.html)
MY (1) MY121114A (cg-RX-API-DMAC7.html)
NO (1) NO319342B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ511554A (cg-RX-API-DMAC7.html)
PE (1) PE20001304A1 (cg-RX-API-DMAC7.html)
PL (1) PL194020B1 (cg-RX-API-DMAC7.html)
PT (1) PT1128831E (cg-RX-API-DMAC7.html)
RU (1) RU2230555C9 (cg-RX-API-DMAC7.html)
SI (1) SI1128831T1 (cg-RX-API-DMAC7.html)
SK (1) SK283936B6 (cg-RX-API-DMAC7.html)
SV (1) SV1999000194A (cg-RX-API-DMAC7.html)
TR (1) TR200101310T2 (cg-RX-API-DMAC7.html)
TW (1) TW580388B (cg-RX-API-DMAC7.html)
UA (1) UA72483C2 (cg-RX-API-DMAC7.html)
UY (1) UY25792A1 (cg-RX-API-DMAC7.html)
WO (1) WO2000027398A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200103141B (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
EP1663226A1 (en) * 2003-09-03 2006-06-07 Ranbaxy Laboratories Limited Pharmaceutical compositions of moxifloxacin and processes for their preparation
CN1330306C (zh) * 2004-08-11 2007-08-08 深圳市天一时科技开发有限公司 莫西沙星明胶胶囊剂及其制备方法
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
WO2007033522A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
CN100363001C (zh) * 2005-09-21 2008-01-23 深圳市天一时科技开发有限公司 一种莫西沙星胶囊剂及其制备方法
PL2349220T3 (pl) * 2008-10-09 2012-12-31 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Zastosowanie rozpuszczalników organicznych w granulacji na mokro moksyfloksacyny
EP2735307A1 (de) 2008-12-08 2014-05-28 Ratiopharm GmbH Kompaktiertes Moxifloxacin
TR200907227A2 (tr) * 2009-09-18 2011-04-21 Bi̇lgi̇ç Mahmut Çözünürlüğü yüksek stabil mikronize granüller.
CN101890169B (zh) * 2009-11-16 2013-09-11 江苏亚邦强生药业有限公司 莫西沙星口服制剂及其制备方法
WO2011086577A2 (en) * 2010-01-12 2011-07-21 Msn Laboratories Limited Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
CN102247313A (zh) * 2010-06-11 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服缓释固体制剂
CN102247314A (zh) * 2011-01-12 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服固体制剂
EP2510929A1 (en) * 2011-04-11 2012-10-17 Innocoll Technologies Limited Methods for treating bacterial infection
MX2011004759A (es) 2011-05-04 2012-11-21 Senosiain S A De C V Lab Nuevas formas solidas de antibioticos.
RU2466718C1 (ru) * 2011-10-14 2012-11-20 Закрытое акционерное общество "Брынцалов-А" Фармацевтический препарат моксифлоксацина
WO2013063271A1 (en) * 2011-10-25 2013-05-02 U.S. Phytotherapy, Inc. Artemisinin and berberine compositions and methods of making
EP2770985A4 (en) 2011-10-25 2015-01-21 U S Phytotherapy Inc ARTEMISININE AND BERBERINE COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
US9675582B2 (en) 2011-10-25 2017-06-13 U.S. Phytotherapy, Inc. Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
US9358261B2 (en) 2011-10-25 2016-06-07 U.S. Phytotherapy, Inc. Additional artemisinin and berberine compositions and methods of making
WO2013081044A1 (ja) * 2011-11-30 2013-06-06 富山化学工業株式会社 1-シクロプロピル-8-(ジフルオロメトキシ)-7-[(1r)-1-メチル-2,3-ジヒドロ-1h-イソインドール-5-イル]-4-オキソ-1,4-ジヒドロキノリン-3-カルボン酸のメタンスルホン酸塩水和物含有錠剤
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
CN102525982A (zh) * 2012-02-21 2012-07-04 天津市汉康医药生物技术有限公司 一种稳定的盐酸莫西沙星药物组合物
CN102600093B (zh) * 2012-04-11 2013-06-05 南京优科生物医药有限公司 一种莫西沙星片剂及其制备方法
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN103768063B (zh) * 2012-10-19 2016-04-20 深圳信立泰药业股份有限公司 一种盐酸莫西沙星药物组合物及其制备方法
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
WO2015093669A1 (ko) * 2013-12-20 2015-06-25 씨제이헬스케어 주식회사 목시플록사신 수성 제형 및 이의 제조방법
RU2558932C1 (ru) * 2014-05-22 2015-08-10 Открытое Акционерное Общество "Татхимфармпрепараты" Фармацевтическая композиция моксифлоксацина и способ ее приготовления

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0350733A2 (de) * 1988-07-15 1990-01-17 Bayer Ag 7-(1-Pyrrolidinyl)-3-chinolon- und -naphthyridoncarbon-säure-Derivate, Verfahren zu ihrer Herstellung sowie substituierte mono-und bicyclische Pyrrolidinderivate als Zwischenprodukte zu ihrer Herstellung, und sie enthaltende antibakterielle Mittel und Futterzusatzstoffe
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
WO1989003681A1 (en) * 1987-10-19 1989-05-05 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 6.8−ジフルオロ−1−(2−フルオロエチル)−1,4−ジヒドロ−7−(4−メチル−1−ピペラジニル)−4−オキソ−3−キノリンカルボン酸を有効成分とする錠剤
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
TW209865B (cg-RX-API-DMAC7.html) * 1992-01-10 1993-07-21 Bayer Ag
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0350733A2 (de) * 1988-07-15 1990-01-17 Bayer Ag 7-(1-Pyrrolidinyl)-3-chinolon- und -naphthyridoncarbon-säure-Derivate, Verfahren zu ihrer Herstellung sowie substituierte mono-und bicyclische Pyrrolidinderivate als Zwischenprodukte zu ihrer Herstellung, und sie enthaltende antibakterielle Mittel und Futterzusatzstoffe
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
AU745282B2 (en) 2002-03-21
CU23260B7 (es) 2008-01-24
RU2230555C2 (ru) 2004-06-20
SV1999000194A (es) 2000-10-16
HN1999000183A (es) 1999-11-01
UY25792A1 (es) 2001-08-27
SI1128831T1 (en) 2005-04-30
ATE279193T1 (de) 2004-10-15
PL194020B1 (pl) 2007-04-30
SK283936B6 (sk) 2004-05-04
BG64974B1 (bg) 2006-11-30
PT1128831E (pt) 2005-01-31
BR9915208A (pt) 2001-07-31
DE59910858D1 (de) 2004-11-18
AU1267400A (en) 2000-05-29
JP4809978B2 (ja) 2011-11-09
HUP0104762A2 (hu) 2002-05-29
HU229065B1 (en) 2013-07-29
WO2000027398A1 (de) 2000-05-18
UA72483C2 (en) 2005-03-15
EE04418B1 (et) 2005-02-15
IL142642A0 (en) 2002-03-10
BRPI9915208B1 (pt) 2011-11-01
HK1042245B (zh) 2005-03-11
BRPI9915208A (pt) 2001-07-31
HUP0104762A3 (en) 2002-10-28
IL142642A (en) 2006-10-05
SK6102001A3 (en) 2001-12-03
ES2229786T3 (es) 2005-04-16
KR20010089424A (ko) 2001-10-06
NO20012248L (no) 2001-06-06
NO319342B1 (no) 2005-07-18
BRPI9915208B8 (pt) 2021-07-06
KR100650489B1 (ko) 2006-11-28
CA2349161A1 (en) 2000-05-18
CZ20011652A3 (cs) 2001-08-15
US6610327B1 (en) 2003-08-26
RU2230555C9 (ru) 2006-02-27
MY121114A (en) 2005-12-30
HK1042245A1 (en) 2002-08-09
ZA200103141B (en) 2002-05-07
JP2002529415A (ja) 2002-09-10
BG105459A (en) 2001-12-29
NO20012248D0 (no) 2001-05-07
PE20001304A1 (es) 2000-12-30
CN1149993C (zh) 2004-05-19
TR200101310T2 (tr) 2001-10-22
HRP20010332A2 (en) 2002-06-30
MA26757A1 (fr) 2004-12-20
AR021074A1 (es) 2002-06-12
CN1325306A (zh) 2001-12-05
EE200100259A (et) 2002-12-16
PL348112A1 (en) 2002-05-06
NZ511554A (en) 2003-07-25
CO5070571A1 (es) 2001-08-28
DK1128831T3 (da) 2005-01-17
EP1128831A1 (de) 2001-09-05
CZ292069B6 (cs) 2003-07-16
ID29089A (id) 2001-07-26
TW580388B (en) 2004-03-21
CA2349161C (en) 2008-01-29
EP1128831B1 (de) 2004-10-13

Similar Documents

Publication Publication Date Title
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
HUP0300207A3 (en) 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes
EE9700363A (et) Uus anesteseeriva toimega farmatseutiline segu
EE04275B1 (et) Kinoliini derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutilised kompositsioonid
HUP0401567A3 (en) Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
HUP0100101A3 (en) Prostaglandin agonists, pharmaceutical compositions comprising thereof and their use
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
TR200101310T2 (tr) Farmasötik moksifloksasin preparatı.
HUP0303148A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing the compounds and processes for their preparation
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
HUP0204242A3 (en) Novel 1,3-dihydro-2h-indol-2-one derivatives, their preparation and pharmaceutical compositions compositions containing them
HUP0402003A3 (en) Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
FI962952A7 (fi) Delta 12,13-iso-taksolianalogit, niiden antineoplastinen käyttö ja nii tä sisältävät farmaseuttiset koostumukset
HUP0102766A2 (hu) Aminometilkarbonsavszármazékok, gyógyászati alkalmazásuk és ilyen vegyületeket tartalmazó gyógyászati készítmények
HUP0400246A3 (en) 1,2,4-trioxolane antimalarial pharmaceutical compositions and process for their preparation and use
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
ZA200308221B (en) Pharmaceutical compositions for oral and topical administration.
EE200200281A (et) Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks
EE200200342A (et) Asendatud 8-arüülkinoliinid, nende kasutamine, farmatseutiline kompositsioon ja prekursorühend
HUP0302193A3 (en) 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation thereof and pharmaceutical compositions containing them
HUP0105075A3 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: BAYER HEALTHCARE AG, DE

PPPP Transfer of rights

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE

B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: BAYER PHARMA AG, DE

PPPP Transfer of rights

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20181005

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20191029